Recombinant Human Olfactory Receptor 56B4 (OR56B4) is a synthetic version of the human olfactory receptor protein, engineered for research purposes. As a member of the G-protein-coupled receptor (GPCR) family, it is designed to mimic the structure and function of its native counterpart, which plays a critical role in detecting odorant molecules in the human olfactory system. The recombinant protein is expressed in heterologous systems such as E. coli or wheat germ cells, enabling large-scale production for biochemical and functional studies .
OR56B4 belongs to the olfactory receptor subfamily 56B, which is part of the largest GPCR family in the human genome . While specific ligands for OR56B4 remain uncharacterized, related olfactory receptors (e.g., OR51E2) are known to bind odorants and modulate intracellular signaling pathways, including:
MAPK activation: Ligand binding induces mitogen-activated protein kinase (MAPK) signaling, influencing cell proliferation .
Ca²⁺ mobilization: Activation triggers intracellular calcium release, a hallmark of GPCR-mediated signaling .
In non-olfactory tissues, such as prostate cancer cells, activation of olfactory receptors can inhibit cell growth, suggesting potential therapeutic applications .
OR56B4 is utilized in diverse experimental contexts, including structural studies, ligand-screening assays, and functional analyses. Key tools and methodologies include:
| Antibody | Host | Applications | Reactivity | Dilution | Source |
|---|---|---|---|---|---|
| PACO01247 | Rabbit | WB, IF, ELISA | Human | WB: 1:500–1:2000, IF: 1:200–1:1000 | |
| A17564 | Rabbit | WB | Human | WB: 1:500–1:2000 |
These polyclonal antibodies target epitopes in the C-terminal (PACO01247) or central regions (A17564) of OR56B4 .
Structural studies: Wheat germ-expressed OR56B4 (GST-tagged) enables conformational analysis of monomeric and dimeric forms via size exclusion chromatography and circular dichroism .
Ligand binding assays: Purified OR56B4 is tested for odorant responses using fluorescence-based methods (e.g., intrinsic tryptophan fluorescence) .
While direct evidence for OR56B4’s role in disease is limited, insights from related olfactory receptors suggest broader applications:
Cancer therapy: Activation of olfactory receptors (e.g., OR51E2) inhibits prostate cancer cell proliferation, highlighting their potential as therapeutic targets .
Diagnostic biomarkers: OR56B4’s expression in blood or other tissues could be explored for disease-associated biomarker discovery .
Ligand identification: High-throughput screening is needed to map OR56B4’s odorant specificity.
Structural elucidation: Crystallization efforts are critical for understanding receptor-ligand interactions.
Functional validation: Studies in native olfactory epithelial cells or transgenic models are required to confirm physiological roles.
Human Olfactory Receptor 56B4 (OR56B4) is a full-length protein consisting of 319 amino acids (1-319aa). It belongs to the class A G-protein-coupled receptors (GPCRs) family, specifically within the olfactory receptor subfamily. The receptor contains a seven-transmembrane domain structure characteristic of GPCRs. The complete amino acid sequence is: MDTSTSVTYDSSLQISQFILMGLPGIHEWQHWLSLPLTLLYLLALGANLLIIITIQHETVLHEPMYHLLGILAVVDIGLATTIMPKILAIFWFDAKAISLPMCFAQIYAIHCFFCIESGIFLCMAVDRYIAICRPLQYPSIVTKAFVFKATGFIMLRNGLLTIPVPILAAQRHYCSRNEIEHCLCSNLGVISLACDDITVNKFYQLMLAWVLVGSDMALVFSSYAVILHSVLRLNSAEAMSKALSTCSSHLILILFHTGIIVLSVTHLAEKKIPLIPVFLNVLHNVIPPALNPLACALRMHKLRLGFQRLLGLGQDVSK .
The receptor is formally known as Olfactory Receptor 56B4 but can also be referenced as:
Olfactory receptor OR11-67 (alternative name)
UniProt accession number: Q8NH76
Part of the CLASS A OLFACTORY RECEPTORS subfamily
OR56B4 is one of approximately 400 intact human odorant receptors. Olfactory receptors constitute the largest transmembrane protein family in the human genome. Based on current research, only about 10% of human olfactory receptors have published ligands. Like other ORs, OR56B4 likely functions within the combinatorial coding scheme of olfaction, where distinct patterns of receptor activation encode different odor perceptions. The receptor's specific ligand profile and response characteristics are still being investigated in comparison to other receptors in this extensive family .
For recombinant expression of OR56B4, the optimal approach based on current protocols involves:
Expression System: E. coli has been successfully used for recombinant OR56B4 production with an N-terminal His tag . For functional studies, mammalian expression systems such as HEK293S cells with tetracycline-inducible promoters are recommended, as demonstrated with other olfactory receptors .
Expression Vector Modifications: Incorporating epitope tags enhances purification efficiency. For OR56B4, an N-terminal His tag has been effectively used. Based on similar OR studies, dual tagging with C-terminal rho1D4 and N-terminal FLAG epitopes can facilitate both purification and detection in functional assays .
Expression Optimization:
Temperature: Typically 30-37°C for E. coli systems
Induction: IPTG at 0.5-1mM for bacterial systems; tetracycline at 1μg/ml for inducible mammalian systems
Duration: 4-24 hours post-induction depending on the expression system
The lyophilized protein should be reconstituted in deionized sterile water to a concentration of 0.1-1.0 mg/mL, with 5-50% glycerol added for long-term storage stability .
Based on similar olfactory receptor purification protocols, a multi-step purification strategy is recommended for OR56B4:
Initial Extraction: Solubilize membrane fractions containing the receptor using appropriate detergents (DDM, CHAPS, or MNG-3 at 1-2% concentration).
Affinity Purification: Utilize the N-terminal His tag with immobilized metal affinity chromatography (IMAC) using Ni-NTA resin. For dual-tagged constructs, anti-FLAG immunoaffinity purification has proven effective for other ORs .
Size Exclusion Chromatography: Further purify using gel filtration to separate monomeric and oligomeric forms. This step is critical as olfactory receptors can exist in both monomeric and dimeric states, as observed with other receptors like hOR1A1 .
Yield Expectations: From sixty T175 flasks of mammalian cells, yields of approximately 1.6 mg of monomeric and 1.1 mg of dimeric receptor forms can be expected, based on comparable OR purification data .
Quality Control: Verify proper folding using circular dichroism analysis and functional activity using ligand binding assays .
Several complementary techniques can be employed to validate the structural integrity of purified OR56B4:
Circular Dichroism (CD) Spectroscopy: Provides information about secondary structure elements and proper folding of the receptor. The CD spectrum should display characteristics consistent with alpha-helical transmembrane proteins .
Size Exclusion Chromatography-Multi-Angle Light Scattering (SEC-MALS): This technique can determine the oligomeric state of the purified receptor, distinguishing between monomeric and dimeric forms. For other ORs, this approach has successfully identified both forms in purified preparations .
Intrinsic Tryptophan Fluorescence Assay: Measures changes in fluorescence upon ligand binding, confirming that the receptor maintains its native conformation capable of ligand interaction. This method has been successfully applied to measure binding affinities in the micromolar range for other olfactory receptors .
SDS-PAGE and Western Blotting: Verifies protein purity, molecular weight, and recognition by tag-specific antibodies. The expected molecular weight for OR56B4 is approximately 35-40 kDa .
Thermal Stability Assays: Techniques such as differential scanning fluorimetry can assess protein stability and the impact of different buffer conditions or ligands on protein folding.
Several cellular assays have proven effective for measuring olfactory receptor activation and can be applied to OR56B4:
Luciferase-Based cAMP Assays: This real-time assay system measures receptor activation through cAMP-dependent luciferase reporter gene expression. The protocol involves:
Co-transfection of HEK293 cells with the OR56B4 construct, RTP1S (5 ng/well), pRL-SV40 (5 ng/well), CRE-luciferase (10 ng/well), and M3 (2.5 ng/well)
Stimulation with potential odorants 24 hours post-transfection
Luminescence measurement 4 hours after odor stimulation
Normalization with Renilla luciferase activity to control for transfection efficiency
Calcium Imaging: Measures intracellular calcium flux upon receptor activation using fluorescent calcium indicators like Fluo-4 or Fura-2.
BRET/FRET-Based Assays: Monitors conformational changes or protein-protein interactions during receptor activation using resonance energy transfer techniques.
Impedance-Based Assays: Measures whole-cell responses to receptor activation in real-time without labels.
For optimal results, the inclusion of receptor transport proteins (RTPs) and other accessory factors is recommended to enhance surface expression and functionality of the receptor in heterologous systems .
Based on established protocols for olfactory receptor ligand identification, an effective screening approach for OR56B4 would include:
Primary Screen Design:
Express OR56B4 in a heterologous system (e.g., Hana3A cells)
Include positive controls (broadly-tuned ORs like OR2W1) and standardization controls
Screen a diverse panel of odorants at 100 μM concentration
Include no-odor controls to establish baseline responses
Normalize responses using standard receptors (e.g., Olfr544 response to nonanedioic acid)
Secondary Screen Design:
Dose-Response Analysis:
Construct dose-response curves using concentrations ranging from 10 nM to 10 mM
Fit data to sigmoidal curves
Confirm agonist activity when:
a) 95% confidence intervals of top and bottom parameters do not overlap
b) Standard deviation of fitted log EC50 is less than 1 log unit
c) Extra sums-of-squares test confirms significant activation compared to vector-only control
Cross-Validation:
Validate hits using orthogonal assays (calcium imaging, BRET)
Confirm specificity by testing structurally related compounds
Examine structure-activity relationships of confirmed ligands
This systematic approach has successfully identified ligands for other olfactory receptors and can be applied to OR56B4 characterization .
Buffer composition significantly impacts the stability and function of olfactory receptors like OR56B4. Key considerations include:
Storage Buffer Composition:
Reconstitution Conditions:
Functional Assay Considerations:
Detergent Selection for Solubilized Receptor:
Ligand Binding Assay Buffers:
Buffers containing physiological ion concentrations (150 mM NaCl)
Presence of divalent cations (1-2 mM CaCl₂ and MgCl₂)
pH maintained at 7.2-7.4
Reducing agents (DTT or TCEP at 0.5-1 mM) to prevent disulfide formation
Optimizing these buffer conditions is critical for maintaining OR56B4 in its native conformation capable of ligand interaction.
OR56B4 oligomerization likely plays a significant role in its function, based on observations from other olfactory receptors:
Oligomeric States:
Size exclusion chromatography-multi-angle light scattering (SEC-MALS) analysis of purified olfactory receptors has demonstrated the presence of both monomeric and dimeric forms. This pattern is likely applicable to OR56B4 as well. The ratio between these forms may be influenced by detergent conditions, lipid environment, and protein concentration .
Functional Implications:
Dimerization of GPCRs, including olfactory receptors, can modulate:
Signal transduction efficiency through altered G-protein coupling
Ligand binding cooperativity (positive or negative)
Receptor trafficking and surface expression
Receptor desensitization and internalization kinetics
Experimental Approaches:
To investigate the impact of OR56B4 oligomerization on function:
Separate monomeric and dimeric forms using SEC
Compare ligand binding properties using intrinsic tryptophan fluorescence assays
Employ resonance energy transfer techniques (FRET/BRET) to study oligomerization dynamics in live cells
Create mutations at potential dimer interfaces to disrupt oligomerization
Analyze the effects of lipids and cholesterol on oligomeric state distributions
Technical Considerations:
Detergent choice significantly impacts observed oligomeric states
Native nanodiscs or styrene maleic acid lipid particles (SMALPs) may better preserve physiologically relevant oligomeric distributions
Crosslinking approaches can stabilize transient interactions for analysis
Understanding the relationship between OR56B4 oligomerization and function may provide insights into the molecular mechanisms of olfactory signal transduction and receptor activation.
Protein Engineering Approaches:
Thermostabilizing mutations identified through alanine scanning or directed evolution
Fusion with crystallization chaperones (T4 lysozyme, BRIL, rubredoxin) between transmembrane helices 5 and 6
N- and C-terminal truncations to remove disordered regions
Introduction of disulfide bridges to stabilize specific conformations
Creation of antibodies or nanobodies against conformational epitopes
Expression Optimization:
Screening multiple expression systems (bacterial, yeast, insect, mammalian)
Codon optimization for the chosen expression host
Use of specialized strains (e.g., C41/C43 for toxic membrane proteins)
Incorporation of N-terminal signal sequences to enhance membrane targeting
Purification Considerations:
Systematic detergent screening to identify optimal extraction and purification conditions
Lipid supplementation during purification to maintain native-like environment
Use of nanodiscs or amphipols for detergent-free structural studies
Monodispersity assessment using FSEC (fluorescence-detection size-exclusion chromatography)
Structural Determination Methods:
X-ray crystallography with lipidic cubic phase (LCP) crystallization
Single-particle cryo-electron microscopy for larger complexes
Solid-state NMR for specific structural elements
Integrative structural biology combining multiple low-resolution techniques
Computational Approaches:
Homology modeling based on related GPCR structures
Molecular dynamics simulations to study conformational dynamics
Deep learning methods (AlphaFold2) for structure prediction
The successful purification of other olfactory receptors like hOR1A1 in milligram quantities suggests that with appropriate optimization, structural studies of OR56B4 are feasible .
Research on OR56B4 can provide significant insights into several aspects of olfactory perception:
Receptor-Ligand Interaction Mechanisms:
Identifying the ligand binding profile of OR56B4 contributes to understanding the combinatorial code of olfaction
Structure-activity relationship studies with various odorants can reveal key molecular determinants of receptor activation
Mutagenesis of binding pocket residues can identify critical amino acids involved in odorant recognition
Evolutionary Perspectives:
Comparative analysis of OR56B4 with orthologous receptors across species provides insights into olfactory adaptation
Investigation of polymorphisms within human populations can reveal the genetic basis for individual differences in odor perception
Correlation between receptor sequence conservation and ligand specificity patterns
Contribution to the Olfactory Receptor Database:
Translational Applications:
Development of biosensors for specific odorant detection
Understanding the molecular basis of olfactory disorders
Design of novel odorants with predicted perceptual qualities
Integration with Systems-Level Olfactory Research:
How OR56B4 activation patterns integrate with other receptors in the olfactory system
Contribution to perceptual qualities of complex odors
Signal integration mechanisms at the olfactory bulb level
This research contributes to filling significant gaps in our understanding of how the human olfactory system discriminates among thousands of odorous compounds through the combinatorial activation of hundreds of receptors .
Olfactory receptors present several expression challenges that researchers working with OR56B4 should anticipate:
Low Surface Expression:
Challenge: Poor trafficking to plasma membrane in heterologous systems
Solution: Co-expression with receptor transport proteins (RTP1S, 5 ng/well) and accessory factors (M3, 2.5 ng/well) significantly enhances surface expression
Alternative: Use specialized cell lines like Hana3A cells that are optimized for OR expression
Protein Misfolding:
Challenge: Aggregation and retention in endoplasmic reticulum
Solution: Lower expression temperatures (28-30°C), addition of chemical chaperones (4-phenylbutyrate, DMSO at low concentrations), and optimized signal sequences
Low Functional Response:
Expression Toxicity:
Post-Expression Handling:
Systematic optimization of these parameters will significantly improve OR56B4 expression outcomes in both cellular assays and purification protocols.
When faced with conflicting ligand binding data for OR56B4, researchers should consider several factors that might contribute to discrepancies:
Expression System Variables:
Different cell lines (HEK293, Hana3A, SF9) may provide varying post-translational modifications
Accessory protein levels (RTPs, REEP) influence surface expression and coupling efficiency
Compare expression levels across systems using quantitative western blotting or flow cytometry
Assay-Dependent Factors:
Ligand Preparation Considerations:
Odorant purity and storage conditions affect activity
Volatile compounds may evaporate during experiments
Stock solutions in DMSO should be prepared fresh and kept at appropriate concentrations
Data Analysis Approach:
Receptor Polymorphisms:
When publishing results, researchers should thoroughly document methodological details and clearly state the criteria used to define positive responses, enabling better comparison across studies.
Several cutting-edge analytical techniques can reveal deeper insights into OR56B4 dynamics and function:
Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS):
Maps conformational changes upon ligand binding
Identifies flexible regions and binding-induced protection patterns
Requires approximately 50-100 μg of purified receptor per condition
Can work with detergent-solubilized receptors or membrane preparations
Single-Molecule FRET (smFRET):
Observes conformational dynamics of individual receptor molecules
Reveals intermediate states and transition kinetics missed in ensemble measurements
Requires strategic placement of fluorophores at conformationally sensitive positions
Can track receptor dynamics in real-time during activation
NMR Spectroscopy:
¹⁹F-NMR with strategically incorporated fluorinated amino acids can probe site-specific conformational changes
Methyl-TROSY approaches provide insights into dynamics of large membrane proteins
Requires isotopic labeling (¹³C, ¹⁵N, ²H) for detailed studies
Can work with detergent-solubilized or nanodisc-reconstituted receptors
Molecular Dynamics Simulations:
All-atom simulations reveal detailed receptor dynamics in membrane environments
Coarse-grained approaches allow longer timescale events to be observed
Enhanced sampling methods (metadynamics, umbrella sampling) can characterize energy landscapes
Integration with experimental data strengthens predictive power
Native Mass Spectrometry:
Determines oligomeric states and ligand binding stoichiometry
Preserves non-covalent interactions during analysis
Compatible with various membrane-mimetic systems (nanodiscs, amphipols)
Requires specialized instrumentation and sample preparation
Microfluidic Diffusional Sizing:
Measures hydrodynamic radius changes upon ligand binding
Works with low protein concentrations (μg range)
Label-free detection of binding events
Rapid analysis suitable for screening multiple conditions
These advanced techniques, when combined with traditional functional assays, provide a comprehensive understanding of OR56B4 structure-function relationships and activation mechanisms.
The study of OR56B4 offers several promising research directions that could significantly advance our understanding of olfactory perception:
Structural Biology: The successful purification strategies developed for other olfactory receptors pave the way for structural determination of OR56B4. Cryo-EM approaches, especially with the advances in obtaining structures of challenging membrane proteins, represent a particularly promising avenue. These structures would provide unprecedented insights into ligand binding mechanisms and receptor activation .
Deorphanization: Identifying the natural ligands of OR56B4 through systematic screening approaches and structure-based virtual screening would expand the limited knowledge base of receptor-ligand pairs in the olfactory system. Currently, only about 10% of human olfactory receptors have published ligands .
Integration into the Olfactory Code: Understanding how OR56B4 activation patterns combine with other receptors to encode odor perception is a critical area for investigation. High-throughput screening methods coupled with machine learning approaches could accelerate this research .
Synthetic Biology Applications: Engineered cells expressing OR56B4 could serve as biosensors for specific environmental chemicals or biomarkers, with applications in environmental monitoring, food safety, and medical diagnostics.
Comparative Genomics: Analysis of OR56B4 orthologs across species could reveal evolutionary adaptations in olfactory perception and provide insights into human-specific olfactory capabilities.
These research directions would contribute valuable data to our understanding of olfactory perception at both molecular and systems levels, with potential applications extending beyond basic science to biotechnology and medicine.
The knowledge gained from OR56B4 research has potential to translate into several broader applications:
Improved In Vitro Olfactory Models: Protocols developed for OR56B4 expression, purification, and functional characterization can be applied to other olfactory receptors, accelerating the development of comprehensive in vitro olfactory systems. These systems could reduce reliance on animal models for fragrance and flavor testing .
Drug Discovery Platforms: Methodologies used to study OR56B4 can inform approaches for other GPCRs, which represent targets for approximately 30-40% of all modern medicines. The heterologous expression systems and screening protocols have broad applicability .
Digital Olfaction Technology: Understanding the molecular recognition properties of OR56B4 contributes to efforts in developing electronic noses and digital olfaction technologies that mimic human smell perception.
Personalized Olfactory Medicine: Knowledge of OR56B4 function could help explain individual variations in odor perception, potentially enabling personalized approaches to conditions involving altered smell sensation.
Evolutionary Biology Insights: The study of OR56B4 in the context of the extensive olfactory receptor family provides a model system for understanding gene family expansion, contraction, and functional diversification, with implications for broader evolutionary biology questions.